×
About 69,640 results

ALLMedicine™ Asthma Center

Research & Reviews  23,968 results

Factors affecting adherence with treatment advice in a clinical trial of patients with ...
https://doi.org/10.1183/13993003.00768-2021
The European Respiratory Journal; Busby J, Matthews JG et. al.

Sep 26th, 2021 - Understanding why patients with severe asthma do not follow healthcare provider (HCP) advice to adjust treatment is critical to achieving personalised disease management. We reviewed patient choice to follow HCP advice to adjust asthma treatment i...

Short-acting β2-agonist prescriptions are associated with poor clinical outcomes of ast...
https://doi.org/10.1183/13993003.01402-2021
The European Respiratory Journal; Bateman ED, Price DB et. al.

Sep 26th, 2021 - To gain a global perspective on short-acting β2-agonist (SABA) prescriptions and associated asthma-related clinical outcomes in patients with asthma, we assessed primary health data across 24 countries in 5 continents. SABINA III was a cross-secti...

EXERCISE-INDUCED BRONCHODILATION EQUALIZES EXERCISE VENTILATORY MECHANICS DESPITE VARIA...
https://doi.org/10.1249/MSS.0000000000002793
Medicine and Science in Sports and Exercise; Rossman MJ, Petrics G et. al.

Sep 25th, 2021 - We quantified the magnitude of exercise-induced bronchodilation in adult asthmatics under conditions of narrowed and dilated airways. We then assessed the effect of the bronchodilation on ventilatory capacity and the extent of ventilatory limitati...

Network Pharmacology Analysis of the Identification of Phytochemicals and Therapeutic M...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8455205
Journal of Immunology Research; Wang J, Peng L et. al.

Sep 25th, 2021 - Paeoniae Radix Alba (PRA), the root of the plant Paeonia lactiflora Pall., has been suggested to play an important role for the treatment of asthma. A biochemical understanding of the clinical effects of Paeoniae Radix Alba is needed. Here, we exp...

see more →

Guidelines  35 results

Managing Asthma in Adolescents and Adults: 2020 Asthma Guideline Update From the Nation...
https://doi.org/10.1001/jama.2020.21974
JAMA Cloutier MM, Dixon AE et. al.

Dec 4th, 2020 - Asthma is a major public health problem worldwide and is associated with excess morbidity, mortality, and economic costs associated with lost productivity. The National Asthma Education and Prevention Program has released the 2020 Asthma Guideline...

Implementation of the Addendum Guidelines for Peanut Allergy Prevention by US allergist...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7590504
The Journal of Allergy and Clinical Immunology; Johnson JL, Gupta RS et. al.

Aug 4th, 2020 - In 2017, the Addendum Guidelines for the Prevention of Peanut Allergy were published with recommendations on early introduction of peanut-containing foods based on infants' clinical history. We sought to conduct a nationwide US survey to assess Gu...

Adult Patients with Respiratory Distress: Current Evidence-based Recommendations for Pr...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7390576
The Western Journal of Emergency Medicine; Hodroge SS, Glenn M et. al.

Jul 30th, 2020 - We developed evidence-based recommendations for prehospital evaluation and treatment of adult patients with respiratory distress. These recommendations are compared with current protocols used by the 33 local emergency medical services agencies (L...

Considerations on biologicals for patients with allergic disease in times of the COVID-...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7300800
Allergy Vultaggio A, Agache I et. al.

Jun 6th, 2020 - The outbreak of the SARS-CoV-2-induced coronavirus disease 2019 (COVID-19) pandemic re-shaped doctor-patient interaction and challenged capacities of healthcare systems. It created many issues around the optimal and safest way to treat complex pat...

Managing Chronic Cough Due to Asthma and NAEB in Adults and Adolescents: CHEST Guidelin...
https://doi.org/10.1016/j.chest.2019.12.021
Chest Côté A, Russell RJ et. al.

Jan 24th, 2020 - Asthma and non-asthmatic eosinophilic bronchitis (NAEB) are among the commonest causes of chronic cough in adults. We sought to determine the role of non-invasive measurements of airway inflammation, including induced sputum and fractional exhaled...

see more →

Drugs  860 results see all →

Clinicaltrials.gov  1 results

Effect of Benralizumab in Patients With Severe Nasal Polyps
https://clinicaltrials.gov/ct2/show/NCT03627286

Aug 14th, 2018 - The aim of this present study is to investigate the use of benralizumab in patients with chronic rhinosinusitis with nasal polyps (CRSwNP), with or without concomitant asthma/ aspirin exacerbated respiratory disease (AERD), whose severity is consi...

see more →

News  2,979 results

Benralizumab Promising for Severe, Chronic Rhinosinusitis With Nasal Polyps
https://www.medscape.com/viewarticle/954835

Jul 15th, 2021 - Benralizumab (Fasenra) significantly reduced nasal polyp score (NPS) and average nasal blockage score (NBS) compared with placebo for patients with severe chronic rhinosinusitis with nasal polyps (CRSwNP) in a phase 3 trial. The randomized, multic...

Tezepelumab Reduces Asthma Exacerbation Rates by 56%
https://www.medscape.com/viewarticle/954777

Jul 14th, 2021 - The US Food and Drug Administration (FDA) has granted priority review for the biologic tezepelumab (AstraZeneca/Amgen) for treatment of severe asthma. The announcement was reported July 8, just days before the start of the European Academy of Alle...

Short-Acting Beta Agonist Overuse 'a Global Public Health Issue'
https://www.medscape.com/viewarticle/954587

Jul 11th, 2021 - About one third of asthma patients have high use of short-acting beta agonists (SABAs) in Europe across all severity levels, said Santiago Quirce, MD, PhD, with Hospital Universitario in Madrid, Spain. High use — defined as three or more canisters...

Dupilumab Safe, Effective in Kids 6-11 With Moderate-to-Severe Asthma
https://www.medscape.com/viewarticle/954586

Jul 10th, 2021 - Dupilumab (Dupixent, Sanofi and Regeneron) significantly reduced exacerbations compared with placebo in children ages 6-11 years who had moderate-to-severe asthma in a phase 3 trial. A fully human monoclonal antibody, dupilumab also improved lung ...

Fast Five Quiz: Severe Asthma Management
https://reference.medscape.com/viewarticle/951633

Jul 7th, 2021 - Asthma is a common, chronic inflammatory disorder of the airways characterized by shortness of breath, wheezing, coughing, chest tightness, variable airflow limitation, and tissue remodeling. Nearly 400 million people around the world have asthma,...

see more →

Patient Education  13 results see all →